Catalyst Wire Dossier Catalyst Wire Dossier

DN24-02

· Dendreon
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DN24-02, covering 2017-05-25 to 2017-05-25. Get the full timeline:

Most recent: Clinical Trial Update: DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma [Phase 2]

See pricing